Close

Piper Sandler Starts Incyte (INCY) at Overweight on diversification into dermatology

January 31, 2023 4:03 AM EST Send to a Friend
(Updated - January 31, 2023 8:37 AM EST)

Piper Sandler analyst Allison Bratzel initiates coverage on Incyte (NASDAQ: INCY) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login